Adding the VEGF inhibitor ramucirumab (Cyramza) to the EGFR inhibitor osimertinib (Tagrisso) slowed progression of untreated EGFR-positive non-small cell lung cancer (NSCLC) by 9 months compared with ...
Very fast SPARQL Engine, which can handle very large knowledge graphs like the complete Wikidata, offers context-sensitive autocompletion for SPARQL queries, and allows combination with text search.